Latest News about RHHBY
Recent news which mentions RHHBY
Recursion Pharmaceuticals has a prescription for high drug costs: AI and 25 petabytes of data
September 08, 2023
From MarketWatch
Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope
September 07, 2023
From Benzinga
Roche's Approved Lung Cancer Drug Beats Chemo In Rare Type Of Lung Cancer
September 01, 2023
From Benzinga
Cancer Treatment In 7 Minutes: UK's Health Service To Rollout Roche's Tencentriq Injection Cutting Treatment Time
August 30, 2023
From Benzinga
3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List
August 28, 2023
From InvestorPlace
From Benzinga
Roche's Accidental Lung Cancer Trial Data Leak: Shows Encouraging Early Data From Combination Therapy Study
August 23, 2023
From Benzinga
Regeneron's Crucial Eylea HD Approval: A Shield Against Potential Biosimilar Competition?
August 21, 2023
From Benzinga
Third Time Lucky: Exelixis' Cabozantinib Combo Therapy Aces Pivotal Study In Prostate Cancer Patients
August 21, 2023
From Benzinga
Is Regeneron Pharmaceuticals Still a Top Growth Stock?
August 21, 2023
From Motley Fool
What's Going On With Sonnet BioTherapeutics Stock Today?
August 16, 2023
From Benzinga
Is TTOO Stock Really Worth $5? Or Just 5 Cents?
August 09, 2023
From InvestorPlace
Is AbbVie Still a Good Dividend Stock to Buy?
August 08, 2023
From Motley Fool
Why Is Aravive Stock Sinking Today?
August 03, 2023
From Benzinga
Johnson & Johnson, Other Pharma Makers Anticipate Reformulated Injectable Drugs May Exclude Price Negotiations
July 28, 2023
From Benzinga
From Benzinga
From Benzinga
Alnylam Inks Co-Development, Co-Commercialization Pact With Roche For Hypertension Therapy
July 24, 2023
From Benzinga
Why Novartis Stock Spiked Today
July 18, 2023
From Motley Fool
2 Nasdaq Stocks That Could Soar This Week
July 16, 2023
From Motley Fool
From Benzinga
From Benzinga
Roche's Approved Multiple Sclerosis Drug: Subcutaneous Injection At Par With Intravenous Infusion
July 13, 2023
From Benzinga
Monkeypox Vaccine: Blue Water Biotech Touts Encouraging Preclinical Data From Monkeypox Vaccine Candidate
June 28, 2023
From Benzinga
Roche's Bispecific Antibody With Fixed-Duration Treatment Scores FDA Approval For Type Of Lymphoma
June 16, 2023
From Benzinga
EyePoint's EYP-1901 Tipped to Transform Wet AMD Market, Analyst Predicts Potential $870M Sales by 2035
June 14, 2023
From Benzinga
New Data Show Roche's Self-Administered Blood Disorder Candidate Achieves Disease Control
June 09, 2023
From Benzinga
AI: An Endless Opportunity or Existential Threat?
June 04, 2023
From InvestorPlace
Why Shares of Zentalis Pharmaceuticals Dropped This Week
June 02, 2023
From Motley Fool
Why Shares of Rain Oncology Are Plummeting Today
May 22, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.